Evidence map›Paper›PMID 33197205›Full record

SynthesisJCO clinical cancer informatics2020

Application of Artificial Intelligence Methods to Pharmacy Data for Cancer Surveillance and Epidemiology Research: A Systematic Review.

Andrew E Grothen, Bethany Tennant, Catherine Wang, Andrea Torres, Bonny Bloodgood Sheppard, Glenn Abastillas, Marina Matatova, Jeremy L Warner, Donna R Rivera

Abstract readSystematic Review
In one paragraph

Synthesis in JCO clinical cancer informatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Machine learning in the prediction of cancer therapy.Computational and structural biotechnology journal · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrew E GrothenSurveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.ORCID 0000-0002-0949-2983
Bethany TennantICF Next, Fairfax, VA.ORCID 0000-0001-8956-1434
Catherine WangSurveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.ORCID 0000-0002-3522-8430
Andrea TorresICF Next, Fairfax, VA.
Bonny Bloodgood SheppardICF Next, Fairfax, VA.
Glenn AbastillasWestat, Rockville, MD.
Marina MatatovaSurveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
Jeremy L WarnerVanderbilt University, Nashville, TN.ORCID 0000-0002-2851-7242
Donna R RiveraSurveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.ORCID 0000-0002-4565-4556

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe implementation and utilization of electronic health records is generating a large volume and variety of data, which are difficult to process using traditional techniques. However, these data could help answer important questions in cancer surveillance and epidemiology research. Artificial intelligence (AI) data processing methods are capable of evaluating large volumes of data, yet current literature on their use in this context of pharmacy informatics is not well characterized.

methodsA systematic literature review was conducted to evaluate relevant publications within four domains (cancer, pharmacy, AI methods, population science) across PubMed, EMBASE, Scopus, and the Cochrane Library and included all publications indexed between July 17, 2008, and December 31, 2018. The search returned 3,271 publications, which were evaluated for inclusion.

resultsThere were 36 studies that met criteria for full-text abstraction. Of those, only 45% specifically identified the pharmacy data source, and 55% specified drug agents or drug classes. Multiple AI methods were used; 25% used machine learning (ML), 67% used natural language processing (NLP), and 8% combined ML and NLP.

conclusionThis review demonstrates that the application of AI data methods for pharmacy informatics and cancer epidemiology research is expanding. However, the data sources and representations are often missing, challenging study replicability. In addition, there is no consistent format for reporting results, and one of the preferred metrics, F-score, is often missing. There is a resultant need for greater transparency of original data sources and performance of AI methods with pharmacy data to improve the translation of these results into meaningful outcomes.

Indexed as

NeoplasmsPharmacyArtificial IntelligenceElectronic Health RecordsHumansNatural Language Processing

Identifiers

PMID33197205
PMCPMC7846043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.